tiprankstipranks
Trending News
More News >
Mesoblast Limited (AU:MSB)
ASX:MSB

Compare Mesoblast Limited (MSB) vs. Competitors

Compare
298 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mesoblast Limited
AU$3.07
AU$3.94B
-23.51
9.25%
3 Buy
0 Hold
0 Sell
Strong Buy
Clinuvel Pharmaceuticals
AU$11.08
AU$634.54M
17.50
10.30%
2 Buy
0 Hold
0 Sell
Moderate Buy
Neuren Pharmaceuticals Limited
AU$19.22
AU$2.43B
16.46
59.11%
4 Buy
0 Hold
0 Sell
Strong Buy
Orthocell Ltd
AU$1.08
AU$293.01M
-30.08
-27.27%
1 Buy
0 Hold
0 Sell
Moderate Buy
Immutep Ltd
AU$0.26
AU$641.07M
-10.31
31.82%
3 Buy
0 Hold
0 Sell
Strong Buy
Prescient Therapeutics Limited
AU$0.08
AU$91.48M
-9.56
74.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:MSB
Mesoblast Limited
3.07
0.26
9.25%
AU:CUV
Clinuvel Pharmaceuticals
12.64
1.52
13.71%
AU:NEU
Neuren Pharmaceuticals Limited
19.22
7.37
62.19%
AU:OCC
Orthocell Ltd
1.08
-0.30
-21.74%
AU:IMM
Immutep Ltd
0.44
0.11
33.85%
AU:PTX
Prescient Therapeutics Limited
0.09
0.04
93.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts